Merck files quarterly report (10-Q) for the period ended Mar 31, 2026

Merck filed its quarterly report on Form 10-Q with the SEC on May 4, 2026, 4:10 PM ET, covering the quarter ended Mar 31, 2026. It reports fiscal Q1 2026 results.

• Revenue: $16.29B (+4.9% from $15.53B a year earlier)
• Net income: −$4.24B (vs $5.08B a year earlier)
• Diluted EPS: $-1.72 (vs $2.01 a year earlier)
• Form 10-Q accepted by EDGAR May 4, 2026, 4:10 PM ET
• Accession number 0001628280-26-029802

SEC filing 10-Q · accession 0001628280-26-029802 · sec.gov ↗